These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7133545)

  • 1. [Changes in serum profile of medium molecules in patients treated with dialysis for various lengths of time].
    Manari A; Buzio C; Calderini C; David S; Montagna G; Quaretti P; Gröf J; Migone L
    Minerva Nefrol; 1982; 29(2):93-100. PubMed ID: 7133545
    [No Abstract]   [Full Text] [Related]  

  • 2. [The calcium-phosphorus balance and parathormone behavior in 7 patients treated with integral hemofiltration].
    Civati G; Guastoni C; Perego A; Galato R; Brando B; Grillo C; Surian M; Colussi G; Teatini U; Minetti L
    Minerva Nefrol; 1981; 28(2):171-4. PubMed ID: 7290521
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemodynamic changes during ultrafiltration and hemodialysis in uremia].
    Wehle B; Asaba H; Castenfors J; Fürst P; Gunnarsson B; Bergström J
    Z Urol Nephrol; 1979 Jan; 72(1):3-8. PubMed ID: 425732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum middle molecules in uremia.
    Buzio C; Manari A; Calderini C; Montagna G; Migone L
    Artif Organs; 1981; 4 Suppl():143-50. PubMed ID: 7295081
    [No Abstract]   [Full Text] [Related]  

  • 5. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients.
    Popławski A; Myśliwiec M
    Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345
    [No Abstract]   [Full Text] [Related]  

  • 6. [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia].
    Popławski A; Myśliwiec M
    Pol Merkur Lekarski; 1996 Oct; 1(4):246-8. PubMed ID: 9156935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term haemodialysis treatment with sodium removal by convection.
    Locatelli F; Pedrini L; Ponti R; Costanzo R; Di Filippo S; Marai P; Pozzi C; Bonacina GP
    Proc Eur Dial Transplant Assoc; 1981; 18():146-52. PubMed ID: 7329962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Substitutive treatment of the uremic diabetic. 8 years of experience and new prospects].
    Triolo G; Thea A; Carta Q; Stratta P; Vacha GM; Giorda G; Paola M; Segoloni GP; Piccoli G; Vercellone A
    Minerva Nefrol; 1981; 28(3):315-20. PubMed ID: 7329609
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood level of middle molecular substances during uraemia and haemodialysis.
    Dzúrik R; Bozek P; Reznícek J; Oborníková A
    Proc Eur Dial Transplant Assoc; 1973; 10(0):263-70. PubMed ID: 4802412
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum oxalate changes in patients undergoing hemodialysis and treated with succinimide].
    Rotolo U; Palazzo Adriano M; Finocchiaro L; Caruselli S; Caramia G; Pavone-Macaluso M
    Minerva Nefrol; 1976; 23(5):403-8. PubMed ID: 1018878
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary note of the changes in cardio-dynamics following acute changes in blood constituants produced by hemo- and peritoneal-dialysis.
    Ambrosi C; Henderson LW; Starr I
    Bibl Cardiol; 1969; 24():85-9. PubMed ID: 5771558
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcome of long-term hemofiltration.
    Baldamus CA; Quellhorst E
    Kidney Int Suppl; 1985 Dec; 17():S41-6. PubMed ID: 3912587
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activation of blood platelets and the plasma coagulation system in patients with chronic uremia].
    Dmoszyńska-Giannopoulou A; Ksiazek A; Baran E; Pachucki Z
    Pol Tyg Lek; 1987 Jul; 42(30):915-7. PubMed ID: 3671183
    [No Abstract]   [Full Text] [Related]  

  • 14. [Regular hemodialysis treatment in the diabetic patient].
    Piccoli G; Triolo G; Thea A; Bosticardo GM; Grivet V; Giorcelli G; Roccatello D; Bossi P; Belardi P; Vercellone A
    Minerva Nefrol; 1982; 29(3 Suppl):45-54. PubMed ID: 7145221
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analysis of the plasma profile of free amino acids and their clearances and removals during brief dialysis treatments].
    Arisi L; Rossi E; Bignardi L; David S; Garini G; Savazzi G; Cambi V; Migone L
    Minerva Nefrol; 1979; 26(1):49-54. PubMed ID: 471321
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior of plasma catecholamines in relation to pressure changes induced with hemodialysis or ultrafiltration].
    Cannella G; Picotti GB; Scolari F; Cancarini GC; Ravazzani C; Cristinelli L; Maiorca R
    Minerva Nefrol; 1979; 26(3):365-72. PubMed ID: 262276
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of isolated ultrafiltration in patients with protracted uremia].
    Luciak M
    Pol Tyg Lek; 1982 Apr; 37(4-5):135-7. PubMed ID: 7050944
    [No Abstract]   [Full Text] [Related]  

  • 18. Purification of blood ultrafiltrate on uncoated charcoal.
    Politi L; Cerullio N; D'Angeloo AR; Scandurra R
    Chin Med J (Engl); 1988 Jun; 101(6):438-43. PubMed ID: 3146477
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes of plasma concentration and elimination of various hormones by haemofiltration.
    Kramer P; Matthaei D; Arnold R; Ebert R; Kobberling D; McIntosh C; Schwinn E; Scheler F; Ludwig H; Reichel J; Spitella G
    Proc Eur Dial Transplant Assoc; 1977; 14():144-50. PubMed ID: 600950
    [No Abstract]   [Full Text] [Related]  

  • 20. [Isolated ultrafiltration and subsequent dialysis in overhydrated patients with chronic renal failure and hypertension].
    Szepietowski T; Abdulla K
    Pol Tyg Lek; 1988 Apr; 43(15):471-4. PubMed ID: 3405878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.